The Sarcopenia Treatment Market will Grow at Highest Pace Owing to Increasing Geriatric Population
The sarcopenia treatment market relies on nutritional supplements, protein supplements, and medical nutrition to treat muscle loss and weakness associated with aging. Sarcopenia often occurs with aging and is caused by the gradual loss of skeletal muscle mass and strength. Proper nutrition and targeted strength and resistance training play a vital role in managing sarcopenia.
The global sarcopenia treatment market is estimated to be valued at US$ 28.19 Bn in 2024 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the sarcopenia treatment market are Abbott Laboratories, Agilent Technologies, Affymetrix Inc., Beckman Coulter, Inc., Illumina Incorporated, Life Technologies Corporation, Randox Laboratories Ltd., Surfix B.V, GE Healthcare, F. Hoffmann-La Roche Ltd, and AYOXXA Biosystems GmbH. The increasing geriatric population worldwide is expected to drive the demand for sarcopenia treatment products in the coming years. Technological advancements are improving the diagnosis and treatment of sarcopenia through better supplements, drugs, and medical devices.
Market Trends
The increasing popularity Sarcopenia Treatment Market Trends. of nutraceuticals for sarcopenia treatment is a key trend in the market. Nutraceuticals containing vitamins, minerals, proteins, and other supplements are gaining importance due to their safety, efficacy, and natural constituents. They help in improving muscle strength and physical performance. Another trend is the growing adoption of myostatin/Activin inhibitors drugs which target specific pathways responsible for muscle loss. Drugs like ACE-031 and Stamulumab are under clinical trials and show promising results for sarcopenia treatment.
Market Opportunities
The growing geriatric population suffering from sarcopenia presents significant opportunities for players. Over 50% of the population aged over 80 years is affected by sarcopenia presenting a large target population base. The untapped markets of developing nations also present lucrative opportunities with growing focus on improving health of the elderly. New product innovation, strategic collaborations and partnerships provide opportunities for market expansion.
Impact of COVID-19 on Sarcopenia Treatment Market Growth
The COVID-19 pandemic has negatively impacted the growth of the sarcopenia treatment market in the initial phases. Sarcopenia Treatment Market Companies Government imposed lockdowns and restrictions on non-essential medical procedures led to declined patient visits and postponed treatment plans. Supply chain disruptions also affected the availability of drugs and dietary supplements. However, with rising awareness about immunity and the role of nutrition in fighting infections, demand for supplements like vitamins, minerals and proteins witnessed an uptick.
As the pandemic progressed, teleconsultations and online pharmacy platforms aided continuation of diagnosis and treatment. This helped restore confidence among the at-risk elderly population. Manufacturers also ramped up production capacity and shipping to cope with the growing needs. It is expected that post-pandemic, the market will observe strong growth prospects as the focus on preventive healthcare and nutrition rises significantly. Players are expected to invest more in R&D for innovative drugs and solutions.
Geographical Region with Highest Market Value
North America dominated the sarcopenia treatment market in terms of value in 2024 owing to rising prevalence of age-related muscle loss, surge in obese population, growing health awareness and high adoption of protein supplements and innovative drugs. The US accounted for the major share due to presence of advanced healthcare facilities and favourable reimbursement policies.
However, Asia Pacific is emerging as the fastest growing regional market and is expected to outpace other regions during the forecast period driven by growing geriatric population, economic development and increasing healthcare expenditures in China and India.
Get More Insight On- Sarcopenia Treatment Market
Explore More Related Article On- Lactulose Market
Unlock More Insights—Explore the Report in the Language You Prefer
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)
Comments on “The Sarcopenia Treatment Market will Grow at Highest Pace Owing to Increasing Geriatric Population”